The group of Yumi MATSUZAKI has isolated ultra-pure MSC isolated from placenta and successfully applied these cells for the treatment of congenital bone metabolic disease (hypophosphatasia) in children.
Nikkei Biotech news release, June 15, 2016
Shimane University Group studies use of mesenchymal stem cells (MSC) in regenerative medicine